Falkovia designs the clinical authority structures, decision rights, and override protocols that healthcare leadership teams need before regulatory or patient safety events force the question.
AI is embedded in clinical workflows, diagnostic support, documentation, scheduling, and revenue cycle management across healthcare systems. Much of it was adopted without formal governance approval. Some of it was never evaluated for patient safety implications. Almost none of it has documented decision authority or override protocols.
The governance gap is not theoretical. State legislatures are passing AI-specific healthcare regulations. CMS is developing AI oversight requirements. Accreditation bodies are issuing AI governance standards. And the plaintiff's bar is already building cases around AI-driven healthcare decisions that lacked documented human oversight.
The question for healthcare leadership is not whether to adopt AI. It is whether the governance architecture exists to make every AI-assisted decision in your system defensible: to your board, your regulators, your accreditors, and a jury.
of healthcare organizations report AI tools in active use that were never formally approved through governance channels
states have introduced or passed AI-specific healthcare legislation since 2023
of clinicians report using AI tools on personal devices or accounts outside institutional oversight
Who in your organization has the documented authority to approve, restrict, or prohibit AI use in clinical workflows, diagnostics, and patient-facing operations?
When an AI-assisted clinical decision is wrong, is there a documented protocol for clinician override, and is it structurally embedded in the workflow, or dependent on individual judgment in the moment?
How many AI tools are being used across your system right now that were never formally approved, evaluated for patient safety, or documented in your governance architecture?
If a state regulator, CMS auditor, or accreditation body asked to see your AI governance documentation tomorrow, what would you hand them?
If an AI-assisted clinical decision led to a patient safety event tonight, does your organization have a documented response protocol, or would leadership be designing one in the middle of a crisis?
Understanding where you stand
Complete inventory of AI tools in use across clinical, operational, and administrative domains, including tools adopted without formal governance approval.
Governance, Use authority, Accountability, Risk management, and Documentation framework customized to your institution's regulatory and accreditation environment.
Role-by-role documentation of who holds authority to approve, restrict, override, and prohibit AI use across every institutional domain.
Building the governance infrastructure
Documented mapping of where human clinical judgment must remain non-delegable, by system, by workflow, by risk level.
Documented protocols for clinician override of AI-assisted decisions, including escalation paths and accountability structures.
Board-ready AI governance charter defining oversight responsibilities, reporting requirements, and fiduciary accountability structures.
Baseline mapping of governance architecture to current state AI legislation, CMS requirements, Joint Commission standards, and applicable federal frameworks.
AI-specific privacy and data governance protocols aligned with HIPAA requirements and institutional data handling standards.
Making it work from day one
Documented protocol for AI-related patient safety events, regulatory inquiries, and public-facing incidents with named accountability and response timelines.
Phased implementation plan with accountability assignments, milestones, and governance maturity benchmarks.
Accountable for institutional AI governance and responsible for ensuring the organization's AI adoption does not create regulatory, legal, or patient safety exposure that reaches the board.
Responsible for clinical quality and patient safety across AI-assisted workflows, diagnostics, and documentation, and accountable when AI-related clinical decisions are questioned.
Managing legal exposure from AI-assisted clinical decisions, regulatory compliance obligations, and the growing landscape of state AI legislation and litigation.
Responsible for regulatory compliance, accreditation readiness, and risk management across an AI landscape that is evolving faster than most compliance frameworks can track.
Exercising fiduciary oversight of AI adoption without operational visibility into how AI is being used in clinical workflows, who approved it, or whether governance structures exist to manage it.
Engagements are confidential, fixed-scope, and designed to produce board-ready governance architecture in 12 weeks.
Start a Confidential Conversation